Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN
Recruiting · NCT06797518 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Impact of Iptacopan on Top of SOC on Biopsy Changes in Kidneys of Adult Patients With IgAN | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, IgA glomerulonephritis, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, nephritis, urinary system disorder | Recruiting | Phase 2 | 2026-07-29 | NCT06797518 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Novartis Pharmaceuticals | 432 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CaRe Research | Chubbuck | United States | 2 |
| Central Florida Kidney Specialists | Orlando | United States | 3 |
| DaVita Clinical Research | Las Vegas | United States | 3 |
| Georgia Nephrology Research Inst | Lawrenceville | United States | 3 |
| OSU Wexner Medical Center | Columbus | United States | 16 |
| Prolato Clinical Research Center | Houston | United States | 22 |
| UCLA Medical Center | Los Angeles | United States | 42 |
| University Hospitals Cleveland Medical Center | Cleveland | United States | 234 |
| University of Alabama at Birmingham | Birmingham | United States | 247 |